EUVIMEDEUVIMED entdecken
Crossref

Nanoscintillator‐Mediated X‐Ray‐Triggered Boosting Transformation of Fe 3+ into Fe 2+ for Enhancing Tumor Ferroptosis/Immunotherapy

Caiju Zhang, Shuting Lu, Kai Deng, Wang Qian, Yue Liu, Yi Li, Shiqi Jin, Ruiyang Suo, Haibo Xu, Bo Wu

Advanced Functional Materials · 2023-11 · 33 (45)

DOI: 10.1002/adfm.202301462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 31.08.2023. Verfasst von Caiju Zhang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis therapy induced by iron‐catalyzed Fenton reaction has offered enormous opportunities for tumor therapy. Unfortunately, high catalytic activity ferrous (Fe 2+ )‐based therapeutic agent has remained challenging due to the instability of Fe 2+ . Herein, an X‐ray‐activated Fe 2+ supply platform, termed “PFCN”, containing the core of CaWO 4 nanoscintillator to emit ultraviolet (UV) light and Fe 3 O 4 decorated on the surface to deliver excessive Fe 2+ is proposed. Under X‐ray excitation, the UV light emitted by CaWO 4 can catalyze ferric (Fe 3+ ) to generate Fe 2+ , which further cascades the Fenton reaction to induce highly toxic hydroxyl radicals generation. More importantly, immunogenic cell death‐associated immunotherapy is simultaneously triggered during this process. Experiments conducted in vitro and in vivo revealed that X‐ray‐triggered PFCN shows superior tumor therapeutic efficacy, contributing i) enhanced radiotherapy; ii) X‐ray‐activated ferroptosis therapy; and iii) ferroptosis/radiotherapy‐induced immunotherapy. Besides, PFCN can be utilized as an MR/CT dual‐mode imaging contrast agent for tumor diagnosis and treatment monitoring. The study provides a novel example of an X‐ray‐activated ferrous‐regeneration platform for imaging‐guided augmenting tumor ferroptosis/immunotherapy

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Fundamental Research Funds for the Central Universities
  • Wuhan University

Zitieren

APA

Zhang, C., Lu, S., Deng, K., Qian, W., Liu, Y., Li, Y., Jin, S., Suo, R., Xu, H., & Wu, B. (2023). Nanoscintillator‐Mediated X‐Ray‐Triggered Boosting Transformation of Fe 3+ into Fe 2+ for Enhancing Tumor Ferroptosis/Immunotherapy. Advanced Functional Materials, 33(45). https://doi.org/10.1002/adfm.202301462

Vancouver

Zhang C, Lu S, Deng K, Qian W, Liu Y, Li Y, et al. Nanoscintillator‐Mediated X‐Ray‐Triggered Boosting Transformation of Fe 3+ into Fe 2+ for Enhancing Tumor Ferroptosis/Immunotherapy. Advanced Functional Materials. 2023;33(45). doi:10.1002/adfm.202301462

BibTeX
@article{Zhang2023,
  author = {Zhang, Caiju and Lu, Shuting and Deng, Kai and Qian, Wang and Liu, Yue and Li, Yi and Jin, Shiqi and Suo, Ruiyang and Xu, Haibo and Wu, Bo},
  title = {Nanoscintillator‐Mediated X‐Ray‐Triggered Boosting Transformation of Fe 3+ into Fe 2+ for Enhancing Tumor Ferroptosis/Immunotherapy},
  journal = {Advanced Functional Materials},
  year = {2023},
  volume = {33},
  number = {45},
  doi = {10.1002/adfm.202301462}
}
Kostenlos starten →